Yeh CF, Chuang TY, Lan MY, Lin YY, Huang WH and [*Hung YW]. 2024. Soluble epoxide hydrolase inhibitor ameliorates olfactory dysfunction, modulates microglia polarization, and attenuates neuroinflammation after ischemic brain injury. Journal of Neuroimmune Pharmacology (accepted)【SCI】I.F. 5.2, 40/354 (11.3%) PHARMACOLOGY & PHARMACY (*corresponding author)
Yeh CF, Lan MY, Lin CC, [Hung YW], Huang WH, Lai YL. 2024. Dual blockade of IL-4 and IL-13 with dupilumab ameliorates sensorineural olfactory dysfunction in mice with eosinophilic sinonasal inflammation. Rhinology (accepted)【SCI】I.F. 4.8, 3/65 (4.6%) OTORHINOLARYNGOLOGY
#Huang WH, [#Hung YW], #Hung W, Lan MY and *Yeh CF. 2024. Murine model of eosinophilic chronic rhinosinusitis with nasal polyposis inducing neuroinflammation and olfactory dysfunction. Journal of Allergy and Clinical Immunology (in press)【SCI】I.F. 14.2, 1/28 (1.8%) ALLERGY (#equal contribution)
[Hung YW], Lu GL, Chen HH, Tung HH and *Lee SL. 2023. Gliptins normalize posttraumatic hippocampal neurogenesis and restore cognitive function after controlled cortical impact on sensorimotor cortex. Biomedicine & Pharmacotherapy 165: 115270.【SCI】I.F. 7.5, 22/278 (7.91%) PHARMACOLOGY & PHARMACY
[Hung YW], Wang Y and *Lee SL. 2020. DPP-4 inhibitor reduces striatal microglial deramification after sensorimotor cortex injury induced by external force impact. FASEB Journal 34: 6950-6964.【SCI】I.F. 4.966, 9/93 (9.6%) BIOLOGY
Yeh CF, Chuang TY, [Hung YW], Lan MY, Tsai CH, Huang HX and *Lin YY. 2019. Soluble epoxide hydrolase inhibition enhances anti-inflammatory and antioxidative process, modulates microglia polarization and promotes recovery after ischemic stroke. Neuropsychiatric Disease and Treatment 15: 2927-2941【SCI】I.F. 2.228, 84/146 (57.53%) PSYCHIATRY
Yeh CF, Chuang TY, [Hung YW], Lan MY, Tsai CH, Huang HX and *Lin YY. 2019. Development of a Modified Surgical Technique for Simulating Ischemic Cerebral Cortex Injury in Rats. In Vivo 33: 1175-1181.【SCI】I.F. 1.609, 102/136 (75%) MEDICINE, RESEARCH & EXPERIMENTAL
Yeh CF, Chuang TY, [Hung YW], Lan MY, Tsai CH, Huang HX and *Lin YY. 2019. Inhibition of soluble epoxide hydrolase regulates monocyte/macrophage polarization and improves neurological outcome in a rat model of ischemic stroke. Neuroreport 30: 567-572.【SCI】I.F. 1.146, 247/267 (92.5%) NEUROSCIENCES
[Hung YW], Lin YH, Chan CY, Wang WS, Chiu CF, Chiu CC, Chiu HW, Tsai WH and *Hung SW. 2019. Pharmacokinetic study of amoxicillin in Japanese eel Anguilla japonica by high performance liquid chromatography with fluorescence detection. Aquaculture Reports 13: 100184.【SCI】I.F. 1.887, 20/52 (38.46%) FISHERIES
[Hung YW], Lin YH, Chen MH, Wang WS, Chiu CF, Chiu CC, Chiu HW, Tsai WH, and *Hung SW. 2018. Pharmacokinetic study of florfenicol in Bester sturgeon, a cultured hybrid of Huso huso×Acipenser ruthenus by high performance liquid chromatography equipped with UV detector. Aquaculture 495: 558-567.【SCI】I.F. 2.710, 17/106 (16.03%) MARINE & FRESHWATER BIOLOGY
[Hung YW] and *Lin YY. Targeting soluble epoxide hydrolase for temporal lobe epilepsy. 2016. Journal of Clinical & Experimental Neuroimmunology 1: 109.
[Hung YW], Hung SW, Wu YC, Wong Lin-Kin, Lai MT, Shih YH, *Lee TS, *Lin YY. 2015. Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy. Brain Behavior and Immunity 43: 118-129.【SCI】I.F. 5.889, 28/252 (11.11%) NEUROSCIENCES (This paper was awarded the Research Paper Publication Award of Post-doctoral Fellow)
[Hung YW], Lai MT, Tseng YJ, Chou CC, and *Lin YY. 2013. Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in rats. Journal of Neuroinflammation 10: 11. 【SCI】I.F. 4.902, 48/252 (19.04%) NEUROSCIENCES
[Hung YW], Yang DI, Huang PY, Lee TS, Kuo TBJ, Yiu CH, Shih YH, and *Lin YY. 2012. The duration of sustained convulsive seizures determines the pattern of hippocampal neurogenesis and the development of spontaneous epilepsy in rats. Epilepsy Research 98: 206-215.【SCI】I.F. 2.290, 87/192 (45.31%) CLINICAL NEUROLOGY